Comparison of the preventive effects of Apixaban and Enoxaparin on the postoperative vascular thromboembolism
Phase 3
Recruiting
- Conditions
- Venous embolism and thrombosis.Other venous embolism and thrombosis
- Registration Number
- IRCT20230419057967N1
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Patients diagnosed with gynecological or colorectal cancers (rectum and colon) undergo laparotomy.
Exclusion Criteria
Use of non-steroidal anti-inflammatory drugs for more than one year
Having other types of cancers
History of thromboembolism
Having severe kidney or liver diseases
Having coagulation or bleeding disorders
Using thrombogenic drugs
Pregnancy or breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The occurrence of major bleeding including hematoma and pelvic and abdominal bleeding. Timepoint: Three times, 30, 60 and 90 days after surgery. Method of measurement: Clinical symptoms and paraclinical findings.;Non-major bleeding incidence with clinical significance (requiring intervention). Timepoint: Three times, 30, 60 and 90 days after surgery. Method of measurement: Clinical symptoms and paraclinical findings.
- Secondary Outcome Measures
Name Time Method